HOXB13 and neoplasm: In five cases with insufficient tumor material and in another case with no match in DNA methylation profiling, immunohistochemistry with antibodies against HOXB13 and MYCN proteins were used as surrogate markers for the methylation types of SP-MPE or SP-EPN-MYCN, respectively.